Page last updated: 2024-10-27

flecainide and Mitral Valve Stenosis

flecainide has been researched along with Mitral Valve Stenosis in 1 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Mitral Valve Stenosis: Narrowing of the passage through the MITRAL VALVE due to FIBROSIS, and CALCINOSIS in the leaflets and chordal areas. This elevates the left atrial pressure which, in turn, raises pulmonary venous and capillary pressure leading to bouts of DYSPNEA and TACHYCARDIA during physical exertion. RHEUMATIC FEVER is its primary cause.

Research Excerpts

ExcerptRelevanceReference
"We report on a 46-year-old woman with ventricular tachycardia and ventricular fibrillation after starting antiarrhythmic drug therapy with flecainide."3.67[Arrhythmogenic effect of flecainide--treatment with i.v. magnesium]. ( Jung, W; Kamradt, T; Lüderitz, B; Manz, M; Mletzko, R; Vogel, F, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mletzko, R1
Jung, W1
Manz, M1
Kamradt, T1
Vogel, F1
Lüderitz, B1

Other Studies

1 other study available for flecainide and Mitral Valve Stenosis

ArticleYear
[Arrhythmogenic effect of flecainide--treatment with i.v. magnesium].
    Zeitschrift fur Kardiologie, 1989, Volume: 78, Issue:9

    Topics: Electrocardiography; Female; Flecainide; Heart Valve Prosthesis; Humans; Magnesium; Middle Aged; Mit

1989